Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 1
2008 2
2009 1
2010 2
2011 1
2012 2
2013 3
2014 2
2015 3
2016 6
2017 1
2018 4
2019 2
2020 10
2021 6
2022 4
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.
Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O, Hingtgen SD, Kabanov AV, Batrakova EV. Kim MS, et al. Among authors: hingtgen sd. Nanomedicine. 2016 Apr;12(3):655-664. doi: 10.1016/j.nano.2015.10.012. Epub 2015 Nov 14. Nanomedicine. 2016. PMID: 26586551 Free PMC article.
Neural stem cell therapy for cancer.
Bagó JR, Sheets KT, Hingtgen SD. Bagó JR, et al. Among authors: hingtgen sd. Methods. 2016 Apr 15;99:37-43. doi: 10.1016/j.ymeth.2015.08.013. Epub 2015 Aug 24. Methods. 2016. PMID: 26314280 Free PMC article. Review.
Intravenously Infused Stem Cells for Cancer Treatment.
Mercer-Smith AR, Findlay IA, Bomba HN, Hingtgen SD. Mercer-Smith AR, et al. Among authors: hingtgen sd. Stem Cell Rev Rep. 2021 Dec;17(6):2025-2041. doi: 10.1007/s12015-021-10192-0. Epub 2021 Jun 17. Stem Cell Rev Rep. 2021. PMID: 34138421 Free PMC article. Review.
A living ex vivo platform for functional, personalized brain cancer diagnosis.
Mann B, Zhang X, Bell N, Adefolaju A, Thang M, Dasari R, Kanchi K, Valdivia A, Yang Y, Buckley A, Lettry V, Quinsey C, Rauf Y, Kram D, Cassidy N, Vaziri C, Corcoran DL, Rego S, Jiang Y, Graves LM, Dunn D, Floyd S, Baldwin A, Hingtgen S, Satterlee AB. Mann B, et al. Among authors: hingtgen s. Cell Rep Med. 2023 Jun 20;4(6):101042. doi: 10.1016/j.xcrm.2023.101042. Epub 2023 May 15. Cell Rep Med. 2023. PMID: 37192626 Free PMC article.
Current approaches in enhancing TRAIL therapies in glioblastoma.
Thang M, Mellows C, Mercer-Smith A, Nguyen P, Hingtgen S. Thang M, et al. Among authors: hingtgen s. Neurooncol Adv. 2023 Apr 21;5(1):vdad047. doi: 10.1093/noajnl/vdad047. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37215952 Free PMC article. Review.
Polymeric Biomaterial Scaffolds for Tumoricidal Stem Cell Glioblastoma Therapy.
Moore KM, Murthy AB, Graham-Gurysh EG, Hingtgen SD, Bachelder EM, Ainslie KM. Moore KM, et al. Among authors: hingtgen sd. ACS Biomater Sci Eng. 2020 Jul 13;6(7):3762-3777. doi: 10.1021/acsbiomaterials.0c00477. Epub 2020 Jun 24. ACS Biomater Sci Eng. 2020. PMID: 33463324 Free PMC article. Review.
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma.
Cheng X, An J, Lou J, Gu Q, Ding W, Droby GN, Wang Y, Wang C, Gao Y, Anand JR, Shelton A, Satterlee AB, Mann B, Hsiao YC, Liu CW, Lu K, Hingtgen S, Wang J, Liu Z, Miller CR, Wu D, Vaziri C, Yang Y. Cheng X, et al. Among authors: hingtgen s. Nat Commun. 2024 Mar 4;15(1):1957. doi: 10.1038/s41467-024-45979-5. Nat Commun. 2024. PMID: 38438348 Free PMC article.
56 results